April 2 (UPI) -- The Food and Drug Administration will have its first public hearing on cannabis and cannabis-derived products on May 31 to get feedback on regulation, manufacturing and marketing.
It's the first step in possible legalization of cannabidiol, a non-psychoactive compound in the cannabis plant that relaxes the body like marijuana, in food and drink products. Cannabidiol, also known as CBD, does not contain THC, the psychoactive component of cannabis. FDA rules currently prohibit restaurant and food manufacturers from adding CBD to food and drinks.